Humankind Ventures Limited
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Humankind Ventures Limited - overview
Established
2016
Location
-, -, UK
Primary Industry
Software
About
Humankind Ventures Limited, operating as Forth, specializes in at-home blood testing services that empower individuals to manage their health through comprehensive and convenient health assessments. Humankind Ventures Limited, founded in 2016 in the UK, provides at-home blood testing services. The company has completed 3 deals with its most recent funding round occurring on November 3, 2021. It raised GBP 1.
6 million with contributions from the Development Bank of Wales and Trajan Capital. The total amount raised by the company is GBP 1. 6 million, and its current valuation stands at GBP 8. 683 million.
The CEO is Sarah Bolt, one of the founders alongside Christopher Baines. Forth specializes in at-home blood testing services, offering a wide range of health assessments focused on personal health management. Their core offerings encompass over 40 blood tests to evaluate hormones, fertility, general health, nutrition, sexual health, and cancer markers. Users can easily collect a small blood sample via a finger-prick, which is sent to Forth’s laboratories for analysis.
Results are provided digitally through an app, delivering clear health scores and actionable guidance, primarily serving consumers in the United Kingdom. Forth uses a direct-to-consumer model to generate revenue through the sale of individual tests and subscriptions for ongoing health monitoring. Customers choose tests based on their health needs, with prices clearly defined for each offering. The company incentivizes new clients through promotional discounts on first purchases.
Transactions are made through their website or app, with results delivered digitally within two working days, supporting recurring revenue from follow-up testing and health management subscriptions. In November 2021, Humankind Ventures Limited secured GBP 1. 6 million in venture funding to enhance its product offerings, specifically developing Female Hormone Mapping services. The company aims to expand its market presence and is exploring entry into new geographic regions to reach a broader consumer base.
Current Investors
Development Bank of Wales, Trajan Capital
Primary Industry
Software
Sub Industries
Medical Software, Analytics & Performance Software
Website
www.forthwithlife.co.uk
Verticals
HealthTech
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
Humankind Ventures Limited - financials
| Fiscal Year Ended | Jun 30, 2025 |
|---|---|
| Revenue (USD) | - |
| % Revenue Growth (YoY) | - |
| EBITDA (USD) | - |
| Operating Income (USD) | - |
| Operating Margin | - |
| % EBITDA Margin | - |
| NET Income (USD) | - |
| % Net Margin | - |
Humankind Ventures Limited - employee data


Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.